Clinical perspectives on human genetic screening to prevent nevirapine toxicity

Author： Haas David W   Mootsikapun Piroon   Ruxrungtham Kiat   Podzamczer Daniel  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.9, Iss.7, 2012-09, pp. : 773-782

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Screening and Ethics: European Perspectives

By Chadwick Ruth   ten Have Henk   Husted Jfrgen   Levitt Mairi   McGleenan Tony   Shickle Darren   Wiesing Urban  

The Journal of Medicine and Philosophy, Vol. 23, Iss. 3, 1998-07 ,pp. : 255-273

Oxford University Press

Access to resources Recommend Favorite

Rapid Detection of the DPYD IVS14+1G>A Mutation for Screening Patients to Prevent Fluorouracil-Related Toxicity

By Bosch Tessa M.  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 2, 2007-01 ,pp. : 105-108

Adis International

Access to resources Recommend Favorite

Rapid Detection of the DPYD IVS14+1G>A Mutation for Screening Patients to Prevent Fluorouracil-Related Toxicity

By Lazar Andreas   Gründemann Dirk   Schömig Edgar  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 5, 2007-01 ,pp. : 341-341

Adis International

Access to resources Recommend Favorite

Retinoblastoma: Genetic Testing versus Conventional Clinical Screening in India

By Joseph Biju  

Molecular Diagnosis, Vol. 8, Iss. 4, 2004-01 ,pp. : 237-243

Adis International

Access to resources Recommend Favorite

Genetic screening

By Chadwick Ruth  

Medicine, Health Care and Philosophy, Vol. 1, Iss. 3, 1998-12 ,pp. : 207-208

Springer Publishing Company

Access to resources Recommend Favorite